1887

oa SA Pharmaceutical Journal - Boniva®: once-monthly oral treatment for postmenopausal osteoporosis : drug info - new product focus

 

Abstract

Boniva® 150 mg tablets contain 150 mg ibandronic acid (ibandronate) per tablet. The tablets are indicated for the treatment of osteoporosis in postmenopausal women in order to reduce the risk of vertebral fractures.

Loading

Article metrics loading...

/content/mp_sapj/83/1/EJC186241
2016-01-01
2016-12-02
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error